6505--Contingency Medication Compounding Services
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contract Office 16, is seeking Contingency Medication Compounding Services for the Michael E. Debakey VA Medical Center in Houston, TX. This combined synopsis/solicitation (RFQ 36C25626Q0332) is for emergency hazardous and non-hazardous medication compounding. Quotes are due by February 18, 2026, at 3:00 PM Central Time.
Scope of Work
The requirement includes the provision of hazardous and non-hazardous agents, IV tubing, closed system drug transfer devices, and other necessary items. Services involve aseptic compounding of agents based on patient-specific orders and transportation of compounded orders to ensure timely delivery. All compounding, labeling, and beyond-use dating/expiration dating must comply with USP 797, USP 800, and Federal Law. Vendors must also provide current and future certification reports for sterile compounding areas and hoods, and submit the "VHA PBM Assessment Guide for Compounded Sterile Preparations within VAMCs and Outsourced Compounding Pharmacies" with their response and annually.
Contract & Timeline
- Contract Type: Firm-fixed price, Indefinite-Delivery-Indefinite-Quantity (IDIQ)
- Period of Performance: One year from the date of award
- Set-Aside: Unrestricted
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 employees
- Quote Due: February 18, 2026, at 3:00 PM Central Time
- Published: February 11, 2026 (Amendment)
Evaluation
Award will be made on a Lowest Price Technically Acceptable (LPTA) basis, resulting in a Firm-Fixed Priced Award. Evaluation factors include Technical (Brand Name or Equal, Contingency Plan) and Price.
Key Clarifications & Submission
An amendment provides answers to vendor questions and extends the submission deadline. Notably, medications from 503B outsourcing facilities will be accepted as long as the 503B pharmacy is licensed by the State or registered by the FDA. Quotes must be submitted electronically via email to Eugene.Jackson2@va.gov. The email subject line must be: "RFQ 36C25626Q0332–Pharmacy Contingency Contract for Hazardous and Non-Hazardous Compounding." Offerors must also complete annual representations and certifications electronically via SAM.gov.